Marta Querol‐Vilaseca

Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid

Alberto Lleó, Raúl Núñez‐Llaves, Daniel Alcolea et al. · Molecular & Cellular Proteomics · 2019 · 242 citations · Full text

Synaptic oligomeric tau in Alzheimer’s disease — A potential culprit in the spread of tau pathology through the brain

Martí Colom‐Cadena, C. T. M. Davies, Sònia Sirisi et al. · Neuron · 2023 · 182 citations · Full text

YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies

Marta Querol‐Vilaseca, Martí Colom‐Cadena, Jordi Pegueroles et al. · Journal of Neuroinflammation · 2017 · 145 citations · Full text

Synaptic phosphorylated α-synuclein in dementia with Lewy bodies

Martí Colom‐Cadena, Jordi Pegueroles, Abigail G. Herrmann et al. · Brain · 2017 · 123 citations · Full text

Synaptic Transmission, Neurochemical Biomarkers, Synaptic Signaling +23

The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders

Daniel Alcolea, Jordi Clarimón, María Carmona‐Iragui et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2019 · 121 citations · Full text